<unk>  (VMA) is a human medical condition where the vitreous gel (or simply vitreous, AKA vitreous humour) of the human eye adheres to the retina in an abnormally strong manner. As the eye ages, it is common for the vitreous to separate from the retina. But if this separation is not complete, i.e. there is still an<unk> , this can create pulling forces on the retina that may result in subsequent loss or distortion of vision. The<unk>  in of itself is not dangerous, but the resulting pathological<unk>  traction (VMT) can cause severe ocular damage. The current standard of care for treating these<unk> s is pars plana vitrectomy (PPV), which involves surgically removing the vitreous from the eye. A biological agent for non-invasive treatment of<unk> s called ocriplasmin has been approved by the FDA on October 17, 2012.
Vitreomacular adhesion
Pellucid marginal degeneration
Optokinetic drum
Enlarged vestibular aqueduct
Vitreous bulge
Blood-spinning
Tooth gemination
Glial scar